RGEBX
Price
$83.64
Change
+$0.75 (+0.90%)
Updated
Aug 21 closing price
Net Assets
342.42B
TBDCX
Price
$13.29
Change
+$0.06 (+0.45%)
Updated
Aug 21 closing price
Net Assets
443.77M
Interact to see
Advertisement

RGEBX vs TBDCX

RGEBX vs TBDCX Comparison Chart in %
View a ticker or compare two or three
VS
RGEBX vs. TBDCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a StrongBuy and TBDCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 342B vs. TBDCX (444M). RGEBX (0.00) and TBDCX (0.00) have matching dividends . RGEBX was incepted earlier than TBDCX: RGEBX (12 years) vs TBDCX (27 years). TBDCX (1.87) is less costly to investors than RGEBX (1.08). TBDCX is a more actively managed with annual turnover of: 122.00 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than TBDCX: RGEBX (250) vs TBDCX (1000). TBDCX annual gain was more profitable for investors over the last year : 5.23 vs. RGEBX (4.65). RGEBX return over 5 years is better than : 13.60 vs. TBDCX (-10.38).
RGEBXTBDCXRGEBX / TBDCX
Total Expense Ratio1.081.8160%
Annual Report Gross Expense Ratio1.081.8758%
Fund Existence12 years27 years-
Gain YTD9.1054.811189%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets342B444M77,027%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.655.2389%
Returns for 3 years43.9935.61124%
Returns for 5 years13.60-10.38-131%
Returns for 10 years92.8439.02238%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM17.191.17
+7.30%
Contineum Therapeutics
MBOT1.500.01
+0.67%
Microbot Medical
HTGC17.130.10
+0.59%
Hercules Capital
MTSI266.610.43
+0.16%
MACOM Technology Solutions Holdings
APVO2.64-0.12
-4.35%
Aptevo Therapeutics Inc